PATENT CLAIM ANALYSIS

Application Number: 16423507
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["424", "211100"]

Abstract:
The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.

Claim (Index 4):
The method of  claim 2 , wherein the neutralizing antibody response is complement independent.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 100.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13982206', '15418626', '14730805', '13608317', '14730809']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6921060841183954
- 35 USC 102 Novelty (BERT): 0.6385162458754373
- Combined Prediction Score: 0.6867471002940995
- Mean Citation Score: 316.86385
- Max Citation Score: 570.1524
- Similarity Product: 565.6499634115219

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test